Logo image of SPNT

SIRIUSPOINT LTD (SPNT) Stock Fundamental Analysis

NYSE:SPNT - New York Stock Exchange, Inc. - BMG8192H1060 - Common Stock - Currency: USD

19.45  -0.12 (-0.61%)

After market: 19.45 0 (0%)

Fundamental Rating

3

Overall SPNT gets a fundamental rating of 3 out of 10. We evaluated SPNT against 144 industry peers in the Insurance industry. SPNT may be in some trouble as it scores bad on both profitability and health. SPNT has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year SPNT was profitable.
In the past year SPNT has reported a negative cash flow from operations.
SPNT had positive earnings in 4 of the past 5 years.
SPNT had a positive operating cash flow in each of the past 5 years.
SPNT Yearly Net Income VS EBIT VS OCF VS FCFSPNT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M

1.2 Ratios

SPNT has a Return On Assets of 1.20%. This is comparable to the rest of the industry: SPNT outperforms 43.75% of its industry peers.
The Return On Equity of SPNT (7.25%) is worse than 65.28% of its industry peers.
Looking at the Return On Invested Capital, with a value of 3.33%, SPNT is in the better half of the industry, outperforming 70.83% of the companies in the same industry.
Industry RankSector Rank
ROA 1.2%
ROE 7.25%
ROIC 3.33%
ROA(3y)0.13%
ROA(5y)0.97%
ROE(3y)1.05%
ROE(5y)2.81%
ROIC(3y)N/A
ROIC(5y)N/A
SPNT Yearly ROA, ROE, ROICSPNT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

SPNT has a Profit Margin (5.20%) which is comparable to the rest of the industry.
SPNT's Profit Margin has declined in the last couple of years.
SPNT's Operating Margin of 16.65% is fine compared to the rest of the industry. SPNT outperforms 72.22% of its industry peers.
SPNT's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 16.65%
PM (TTM) 5.2%
GM N/A
OM growth 3YN/A
OM growth 5Y-4.18%
PM growth 3Y45.15%
PM growth 5Y-20.65%
GM growth 3YN/A
GM growth 5YN/A
SPNT Yearly Profit, Operating, Gross MarginsSPNT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

More info and screens

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SPNT is destroying value.
SPNT has less shares outstanding than it did 1 year ago.
SPNT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, SPNT has an improved debt to assets ratio.
SPNT Yearly Shares OutstandingSPNT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
SPNT Yearly Total Debt VS Total AssetsSPNT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

A Debt/Equity ratio of 0.33 indicates that SPNT is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.33, SPNT is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC0.32
WACC10.29%
SPNT Yearly LT Debt VS Equity VS FCFSPNT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
SPNT Yearly Current Assets VS Current LiabilitesSPNT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

5

3. Growth

3.1 Past

SPNT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -42.86%.
The earnings per share for SPNT have been decreasing by -14.97% on average. This is quite bad
Looking at the last year, SPNT shows a small growth in Revenue. The Revenue has grown by 3.02% in the last year.
Measured over the past years, SPNT shows a very strong growth in Revenue. The Revenue has been growing by 22.87% on average per year.
EPS 1Y (TTM)-42.86%
EPS 3Y-21.17%
EPS 5Y-14.97%
EPS Q2Q%0%
Revenue 1Y (TTM)3.02%
Revenue growth 3Y8.91%
Revenue growth 5Y22.87%
Sales Q2Q%-8.58%

3.2 Future

SPNT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 44.67% yearly.
Based on estimates for the next years, SPNT will show a small growth in Revenue. The Revenue will grow by 6.61% on average per year.
EPS Next Y129.5%
EPS Next 2Y61.39%
EPS Next 3Y44.67%
EPS Next 5YN/A
Revenue Next Year8.06%
Revenue Next 2Y7.35%
Revenue Next 3Y6.61%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SPNT Yearly Revenue VS EstimatesSPNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
SPNT Yearly EPS VS EstimatesSPNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 20.26, the valuation of SPNT can be described as rather expensive.
Compared to the rest of the industry, the Price/Earnings ratio of SPNT indicates a slightly more expensive valuation: SPNT is more expensive than 65.97% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.65, SPNT is valued a bit cheaper.
SPNT is valuated cheaply with a Price/Forward Earnings ratio of 7.78.
68.75% of the companies in the same industry are more expensive than SPNT, based on the Price/Forward Earnings ratio.
SPNT is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.27, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 20.26
Fwd PE 7.78
SPNT Price Earnings VS Forward Price EarningsSPNT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

81.94% of the companies in the same industry are more expensive than SPNT, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.58
SPNT Per share dataSPNT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SPNT's earnings are expected to grow with 44.67% in the coming years.
PEG (NY)0.16
PEG (5Y)N/A
EPS Next 2Y61.39%
EPS Next 3Y44.67%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SPNT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SIRIUSPOINT LTD

NYSE:SPNT (6/24/2025, 4:15:01 PM)

After market: 19.45 0 (0%)

19.45

-0.12 (-0.61%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)05-05 2025-05-05/amc
Earnings (Next)07-30 2025-07-30
Inst Owners88.44%
Inst Owner Change5.23%
Ins Owners2.12%
Ins Owner Change1.13%
Market Cap2.27B
Analysts82.5
Price Target20.4 (4.88%)
Short Float %2.19%
Short Ratio3.28
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.11
Dividend Growth(5Y)N/A
DP10.9%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-11.5%
Min EPS beat(2)-131.86%
Max EPS beat(2)108.87%
EPS beat(4)2
Avg EPS beat(4)-6.12%
Min EPS beat(4)-131.86%
Max EPS beat(4)108.87%
EPS beat(8)6
Avg EPS beat(8)50.93%
EPS beat(12)7
Avg EPS beat(12)14.93%
EPS beat(16)10
Avg EPS beat(16)14.42%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)17.65%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.78%
EPS NY rev (3m)8%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)11.59%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 20.26
Fwd PE 7.78
P/S 0.8
P/FCF N/A
P/OCF N/A
P/B 1.12
P/tB 1.2
EV/EBITDA 4.58
EPS(TTM)0.96
EY4.94%
EPS(NY)2.5
Fwd EY12.86%
FCF(TTM)-0.6
FCFYN/A
OCF(TTM)-0.6
OCFYN/A
SpS24.19
BVpS17.37
TBVpS16.19
PEG (NY)0.16
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.2%
ROE 7.25%
ROCE 3.83%
ROIC 3.33%
ROICexc 3.54%
ROICexgc 4.96%
OM 16.65%
PM (TTM) 5.2%
GM N/A
FCFM N/A
ROA(3y)0.13%
ROA(5y)0.97%
ROE(3y)1.05%
ROE(5y)2.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-10.36%
ROICexc growth 3YN/A
ROICexc growth 5Y-11.48%
OM growth 3YN/A
OM growth 5Y-4.18%
PM growth 3Y45.15%
PM growth 5Y-20.65%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Debt/EBITDA 1.38
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC10.29%
ROIC/WACC0.32
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-42.86%
EPS 3Y-21.17%
EPS 5Y-14.97%
EPS Q2Q%0%
EPS Next Y129.5%
EPS Next 2Y61.39%
EPS Next 3Y44.67%
EPS Next 5YN/A
Revenue 1Y (TTM)3.02%
Revenue growth 3Y8.91%
Revenue growth 5Y22.87%
Sales Q2Q%-8.58%
Revenue Next Year8.06%
Revenue Next 2Y7.35%
Revenue Next 3Y6.61%
Revenue Next 5YN/A
EBIT growth 1Y31.31%
EBIT growth 3YN/A
EBIT growth 5Y17.74%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-118.07%
FCF growth 3Y260.08%
FCF growth 5Y-11.94%
OCF growth 1Y-118.07%
OCF growth 3Y260.08%
OCF growth 5Y-11.94%